Abstract
Tuberculosis vaccine research began with the search for a vaccine that might be better than, and thus could replace, the current Bacillus Calmette Guérin (BCG) vaccine. Over the last fifteen years or so, intense research effort has led to the identification of a number of novel tuberculosis (TB) vaccines which can be divided into 4 categories: genetically modified mycobacteria, protein, plasmid DNA and viral. However, it is increasingly believed that the current BCG vaccine will continue to be used as a childhood vaccine and that more effort should be directed to developing appropriate boosting vaccines. Mounting evidence suggests that recombinant genetic vaccines, particularly recombinant viral vaccines, are effective in boosting immune activation and protection by BCG vaccination. Since modified vaccinia virus Ankara (MVA)- and adenovirus-vectored TB vaccines have been most extensively studied, this review will focus on recent advances in the development and applications of these two viral TB vaccines.
Keywords: modified vaccinia virus Ankara, cmv promoters, gag gene, bcg vaccination, bovine models, genetically modified dendritic cell, immunopathology
Current Gene Therapy
Title: Recent Advances in the Development of Adenovirus- and Poxvirus- Vectored Tuberculosis Vaccines
Volume: 5 Issue: 5
Author(s): Zhou Xing, Michael Santosuosso, Sarah McCormick, Teng-Chih Yang, James Millar, Mary Hitt, Yonghong Wan, Jonathan Bramson and H. M. Vordermeier
Affiliation:
Keywords: modified vaccinia virus Ankara, cmv promoters, gag gene, bcg vaccination, bovine models, genetically modified dendritic cell, immunopathology
Abstract: Tuberculosis vaccine research began with the search for a vaccine that might be better than, and thus could replace, the current Bacillus Calmette Guérin (BCG) vaccine. Over the last fifteen years or so, intense research effort has led to the identification of a number of novel tuberculosis (TB) vaccines which can be divided into 4 categories: genetically modified mycobacteria, protein, plasmid DNA and viral. However, it is increasingly believed that the current BCG vaccine will continue to be used as a childhood vaccine and that more effort should be directed to developing appropriate boosting vaccines. Mounting evidence suggests that recombinant genetic vaccines, particularly recombinant viral vaccines, are effective in boosting immune activation and protection by BCG vaccination. Since modified vaccinia virus Ankara (MVA)- and adenovirus-vectored TB vaccines have been most extensively studied, this review will focus on recent advances in the development and applications of these two viral TB vaccines.
Export Options
About this article
Cite this article as:
Xing Zhou, Santosuosso Michael, McCormick Sarah, Yang Teng-Chih, Millar James, Hitt Mary, Wan Yonghong, Bramson Jonathan and Vordermeier M. H., Recent Advances in the Development of Adenovirus- and Poxvirus- Vectored Tuberculosis Vaccines, Current Gene Therapy 2005; 5 (5) . https://dx.doi.org/10.2174/156652305774329230
DOI https://dx.doi.org/10.2174/156652305774329230 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Direct Modification of Bioactive Phenothiazines by Exposure to Laser Radiation
Recent Patents on Anti-Infective Drug Discovery Purine and Pyrimidine Pathways as Targets in Plasmodium falciparum
Current Topics in Medicinal Chemistry Antimicrobial and Antifungal Properties of Leaves to Root Extracts and Saponin Fractions of <i>Chlorophytum borivilianum</i>
Current Bioactive Compounds Bronchoscopy in Children for Research with Questionable Indications: An Overview of Russian Patents and Publications
Recent Patents on Drug Delivery & Formulation Persistent Clinical Response of Infliximab Therapy in Patients with Refractory Rheumatoid Arthritis, over a 3-Year Period
Current Clinical Pharmacology Complement 3 Receptor Expression in Individuals with Type 2 Diabetes
Recent Patents on Anti-Infective Drug Discovery Combinatorial Approaches to Iminosugars as Glycosidase and Glycosyltransferase Inhibitors
Combinatorial Chemistry & High Throughput Screening Conducting HIV Seroprevalence and Behavioral Epidemiology Risk Surveys (SABERS) Among Partner Military Populations
Current HIV Research A Brief Survey on Computational Approaches to Reveal Drug and Disease Associations
Current Drug Discovery Technologies Gold Coordination Complexes as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Protective Effect of Algerian <i>Genista vepres</i> Pomel Plant Against Isoniazid and Rifampicin Induced Liver Injury in <i>Wistar Albino</i> Rats
Current Bioactive Compounds Activation of the Liver X Receptor Inhibits Th17 and Th1 Responses in Behcet`s Disease and Vogt-Koyanagi-Harada Disease
Current Molecular Medicine Selected Pharmaceutical Excipient Prevent Isoniazid and Rifampicin Induced Hepatotoxicity
Current Drug Metabolism Drugs that Inhibit Mycolic Acid Biosynthesis in Mycobacterium tuberculosis - An Update
Medicinal Chemistry Reviews - Online (Discontinued) Anti-Inflammatory Properties of Drugs from saffron crocus
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Allopurinol and Loss of Consciousness in a 78-old Year Man Suffering from Gout
Infectious Disorders - Drug Targets Present and Future Treatment of Mycobacteria
Anti-Infective Agents in Medicinal Chemistry Predictors of Response to TNF Antagonists
Current Pharmaceutical Design Human Leukocyte Antigens Class I and Class II: Associations and Distribution in Different Ethnic Groups of Patients with Pulmonary Tuberculosis
Current Respiratory Medicine Reviews Vitamin, Mineral, and Drug Absorption Following Bariatric Surgery
Current Drug Metabolism